Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young.
Kovács G. et al, (2023), Per Med
Lessons learned from the application of the HEcoPerMed guidance to three modeling case studies.
Nagy B. et al, (2023), Per Med
Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK.
Koleva-Kolarova R. et al, (2023), Per Med
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries
Szilberhorn L. et al, (2023), Personalized Medicine
Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation
Koleva-Kolarova R. et al, (2023), Personalized Medicine
Budget impact and transferability of cost–effectiveness of DPYD testing in metastatic breast cancer in three health systems
Koleva-Kolarova R. et al, (2023), Personalized Medicine
Cost-effectiveness of alternative NTRK testing strategies in cancer patients followed by histology-independent therapy with entrectinib: an analysis of three European countries.
Vellekoop H. et al, (2023), Per Med, 20, 321 - 338
HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead.
Rutten-van Mölken M. et al, (2023), Personalized medicine, 20, 299 - 303
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies.
Harris J. et al, (2023), Health Technol Assess, 27, 1 - 257
Introduction to economic evaluation in health sciences
Mitropoulou C. et al, (2023), Economic Evaluation in Genomic and Precision Medicine, 1 - 14
Preface
Mitropoulou C. et al, (2023), Economic Evaluation in Genomic and Precision Medicine, xiii - xiv
Using “big data” for economic evaluations in genomics
Wordsworth S. et al, (2023), Economic Evaluation in Genomic and Precision Medicine, 113 - 121
Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT.
Lim E. et al, (2022), Health Technol Assess, 26, 1 - 162
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.
Robbe P. et al, (2022), Nat Genet
Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib.
Huygens S. et al, (2022), Value Health
Resource allocation in genetic and genomic medicine.
Buchanan J. et al, (2022), Journal of community genetics, 13, 463 - 466